Associated Press Cites Public Citizen on FDA Review of Alzheimer’s Drug
By Marilynn Marchione and Matthew Perrone
“The drug is expected to be very expensive and ‘could bankrupt our health care system’ while giving patients false hope, the consumer group Public Citizen warned.”